ADM and susceptibility to pneumonia measurement: Among other biomarkers for inflammation, procalcitonin (PCT) had limited added value in the diagnosis of pneumonia in this setting and studies on the prognostic value of the adrenomedullin precursor, mid-regional pro-adrenomedullin (MR-proADM), are currently lacking [7].